Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-17Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic [NA]
A completed clinical trial evaluated transcranial direct current stimulation for treating cognitive deficits in schizophrenia.
-
CLINICAL_TRIALS withdrawal · 2019-01-17Clinical Trial Update: Sodium Butyrate For Improving Cognitive Function In Schizophrenia [Phase 2, Phase 3]
A clinical trial evaluating sodium butyrate for improving cognitive function in schizophrenia has been withdrawn from Phase 2/Phase 3.
-
FDA approval · 2019-01-16FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
The FDA approved a supplemental application for Clozaril (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA label_change · 2019-01-16FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for Versacloz (clozapine) by TruPharma LLC. The action updates the product labeling.
-
FDA approval · 2019-01-16FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application to authorize a generic version of Clozapine manufactured by Mylan Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-01-16FDA Approved: CLOZAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's supplemental application for clozapine (generic) under ANDA202873.
-
FDA approval · 2019-01-16FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Clozapine from Aurobindo Pharma Limited.
-
FDA approval · 2019-01-16FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves Teva Pharmaceuticals USA, Inc.'s supplemental application for Clozapine (generic) under the ANDA.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole [Phase 4]
Phase 4 trial update examining adiposity and metabolic measures when switching from atypicals to aripiprazole in schizophrenia patients, wit…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients [Phase 4]
Phase 4 trial update evaluating curcumin added to antipsychotic treatment in chronic schizophrenia.
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia [Phase 4]
Clinical trial update of acupuncture as a treatment for negative symptoms in schizophrenia (Phase 4).
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects [Phase 1]
A Phase 1 pharmacokinetic study of lurasidone in healthy subjects provides PK data following a single oral dose.
-
FDA approval · 2019-01-04FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's generic lurasidone hydrochloride (an Abbreviated New Drug Application) for the treatment of schizophre…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's generic lurasidone hydrochloride via an Original Application (ANDA). The generic is indicated for schizophr…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic lurasidone hydrochloride under an Original ANDA, expanding access to this antipsychotic as a gen…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Exelan Pharmaceuticals Inc.)
FDA approved Exelan Pharmaceuticals Inc.'s original application for lurasidone hydrochloride (generic lurasidone) capsules.
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approves Amneal's generic LURASIDONE HYDROCHLORIDE (ANDA) for the same indications as the brand Latuda. These indications include schizo…
-
FDA approval · 2019-01-03FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's Original Application for Lurasidone Hydrochloride (generic lurasidone) for marketing in the U…
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005) [Phase 2]
Results from an active-controlled Phase 2 study of MK-8189 in adults with schizophrenia (acute episode) have been posted. The trial status w…
-
CLINICAL_TRIALS trial_result · 2018-12-26Clinical Trial Update: Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating tocilizumab as add-on therapy for residual positive, negative, and cognitive symptoms in schizophrenia and…
-
CLINICAL_TRIALS trial_result · 2018-12-17Clinical Trial Update: Side Effects of Newer Antipsychotics in Older Adults [Phase 4]
Phase 4 clinical trial update examining side effects of newer antipsychotics in older adults.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia [Phase 4]
A Phase 4 randomized double-blind trial comparing aripiprazole and risperidone in schizophrenia was terminated with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-13Clinical Trial Update: Effects of Oxytocin Nasal Spray on Social Affiliation [Phase 2]
Phase 2 clinical trial evaluating oxytocin nasal spray for social affiliation in schizophrenia has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Electronic Decision Support Systems for Smokers With Severe Mental Illness [NA]
Clinical trial evaluating electronic decision support systems for smokers with severe mental illness has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Clinical Trial of Dipyridamole in Schizophrenia [NA]
Clinical trial of dipyridamole in schizophrenia and schizoaffective disorder completed; results posted.